Medication info

Samsung Ibuprofen Premix Injection

Prescription medicationInjections
Ingredient · strength
Ibuprofen›400mg
Manufacturer / importer
Samsung Pharmaceutical Co., Ltd.
Appearance
A colorless or light yellow liquid filled in a colorless transparent plastic container for injection.
Packaging
100 milliliters/vial, 200 milliliters/vial
Approval status
Active

MFDS item code 202202348 · Approved 2022.06.07

Summary

Main use
Adjunct to opioid analgesics for the management of moderate to severe pain; reduction of fever
Who uses it
Adults · Children
Adult dosage
Administer the lowest effective dose of this medicine that meets the treatment goals of each patient for the shortest duration. After the initial dose, adjust the dose and frequency of administration appropriately according to the patient's condition. This medicine is a premixed preparation and must be administered undiluted. Use only when one unit package per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for use. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain ⦁ Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. (2) Fever reduction ⦁ Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. Before administration, visually inspect the injectable product for particulate matter or discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.
Children's dosage
6 months to under 12 years: Administer 10mg/kg per dose (up to a maximum of 400mg) intravenously every 4~6 hours as needed. The administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever dose is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed. The administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.

Ingredients

Manufacturer
Samsung Pharmaceutical Co., Ltd.

Efficacy & effects

Adjunct to opioid analgesics for the management of moderate to severe pain; reduction of fever

  • Moderate pain
  • severe pain
  • fever
View approved original text

This medication is used as an adjunct therapy for controlling moderate to severe pain in combination with narcotic analgesics, thereby enhancing pain relief effects. It is also effective as an antipyretic for use in cases of fever. In other words, this drug helps manage both pain and fever together.

Dosage and Administration

Adult dosage

Administer the lowest effective dose of this medicine that meets the treatment goals of each patient for the shortest duration. After the initial dose, adjust the dose and frequency of administration appropriately according to the patient's condition. This medicine is a premixed preparation and must be administered undiluted. Use only when one unit package per dose (ibuprofen 400mg or 800mg) can replace the required dose; do not divide the contents for use. Adults may receive up to 3200mg per day. To reduce the risk of renal adverse reactions, ensure that the patient is adequately hydrated before administration. (1) Adjunctive therapy to opioid analgesics (morphine) for the management of moderate to severe pain ⦁ Adults (17 years and older): Administer 400mg-800mg intravenously every 6 hours as needed. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. (2) Fever reduction ⦁ Adults (17 years and older): Administer 400mg intravenously every 4-6 hours as needed. Depending on the patient's condition, 100-200mg may also be administered every 4 hours after an initial dose of 400mg. Up to 3200mg per day may be administered. The administration time must be at least 30 minutes. Before administration, visually inspect the injectable product for particulate matter or discoloration. Do not use if opaque particles, other contaminants, or discoloration are observed.

Children's dosage

6 months to under 12 years: Administer 10mg/kg per dose (up to a maximum of 400mg) intravenously every 4~6 hours as needed. The administration time must be at least 10 minutes. Up to 40mg/kg or 2,400mg per day may be administered (whichever dose is lower). 12 years to under 17 years: Administer 400mg per dose intravenously every 4~6 hours as needed. The administration time must be at least 10 minutes. Up to 2,400mg per day may be administered.

Precautions

This drug should be used with caution in patients with cardiovascular diseases or risk factors, as there is a higher risk of serious cardiovascular issues such as myocardial infarction and stroke. In addition, serious gastrointestinal side effects such as gastrointestinal bleeding or ulcers may occur, so the elderly or long-term users should be particularly careful. This medication should not be taken by individuals with a history of gastrointestinal ulcers or bleeding, severe liver or kidney impairment, severe hypertension, or allergies to any component of this drug. Those with bronchial asthma or who have experienced hypersensitivity reactions to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) should not use this medication. During late pregnancy, it may pose risks to the fetus, so it should be avoided. Patients undergoing cancer treatment with high-dose methotrexate should also refrain from using this drug. Patients with blood disorders or tendencies to bleed, those with impaired liver or kidney function, the elderly, pregnant women, and nursing mothers should use this drug with caution. If serious allergic reactions or unusual symptoms such as nausea, vomiting, headache, skin rash, or respiratory difficulty occur during treatment, medical consultation should be sought immediately. In particular, patients with hypertension, heart failure, or impaired kidney function should closely monitor their blood pressure and fluid status when taking this drug. This drug should not be used in conjunction with other nonsteroidal anti-inflammatory drugs, and it is recommended to take the lowest effective dose for the shortest duration. Adverse interactions may occur when taken with aspirin, anticoagulants, ACE inhibitors, diuretics, lithium, and methotrexate, so it is paramount to inform healthcare professionals and take necessary precautions. During pregnancy, especially after 20 weeks, it may affect fetal kidney function, so amniotic fluid status should be monitored. In breastfeeding women, this medication may pass into breast milk, so considering discontinuation of breastfeeding or the medication itself is advised. Safety and effectiveness have not been established for children under 6 months, and the elderly may have decreased bodily functions, necessitating dose adjustment and close monitoring. In cases of overdose, serious symptoms such as dizziness, nausea, vomiting, kidney failure, respiratory difficulties, and hypotension may occur, and immediate medical attention should be sought if symptoms are suspected.

Side effects

  • Cardiovascular thrombotic response
  • myocardial infarction
  • stroke
  • gastrointestinal bleeding
  • ulcer
  • perforation
  • shock
  • anaphylactic reaction
  • mimicry
  • chills
Show 135 more
  • dyspnea
  • hypotension
  • decreased hematocrit
  • decreased hemoglobin
  • anemia
  • aplastic anemia
  • hemolytic anemia
  • agranulocytosis
  • granulocytopenia
  • leukopenia
  • thrombocytopenia
  • impaired platelet function
  • eosinophilia
  • peptic ulcer
  • gastrointestinal ulcer
  • gastric bleeding
  • ulcerative colitis
  • bloody stools
  • gastritis
  • pancreatitis
  • hematemesis
  • Crohn's disease
  • loss of appetite
  • nausea
  • vomiting
  • abdominal pain
  • dyspepsia
  • diarrhea
  • discomfort in the upper stomach
  • epigastric pain
  • thirst
  • stomatitis
  • abdominal bloating
  • oral ulcer
  • constipation
  • melena
  • skin mucosal syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • Riel syndrome
  • photosensitive reaction
  • drug rash
  • angioedema
  • vesicular dermatitis
  • polymorphic erythema
  • papular rash
  • skin redness
  • vesicles
  • rash
  • exfoliative dermatitis
  • acute generalized eruptive pustulosis
  • hepatitis
  • jaundice
  • abnormal liver function
  • liver disorder
  • hypersensitivity
  • anaphylaxis
  • asthma attack
  • urticaria
  • eczema
  • purpura
  • rash
  • pruritus
  • asthma
  • bronchoconstriction
  • dyspnea
  • wheezing
  • scotoma
  • visual impairment
  • hearing loss
  • tinnitus
  • taste alteration
  • dizziness
  • drowsiness
  • vertigo
  • depression
  • headache
  • cerebrovascular accident
  • irritability
  • aseptic meningitis
  • meningitis
  • hypertension
  • palpitations
  • heart failure
  • angina
  • acute renal failure
  • oliguria
  • hematuria
  • proteinuria
  • elevated serum creatinine
  • hyperkalemia
  • interstitial nephritis
  • nephrotic syndrome
  • renal papillary necrosis
  • decreased urine output
  • generalized edema
  • shortness of breath
  • lethargy
  • Conn's syndrome
  • periorbital edema
  • facial edema
  • malaise
  • fever
  • epistaxis
  • edema
  • peripheral edema
  • nausea
  • distension
  • headache
  • hemolysis
  • drowsiness
  • peripheral edema
  • urinary disorders
  • anemia
  • decreased hemoglobin
  • dyspepsia
  • wound hemolysis
  • abdominal discomfort
  • cough
  • hypokalemia
  • eosinophilia
  • hypoproteinemia
  • neutropenia
  • increased hematuria
  • hypernatremia
  • hypertension
  • hypoalbuminemia
  • hypotension
  • diarrhea
  • bacterial pneumonia
  • elevated serum LDH
  • thrombocytosis
  • bacteremia
  • injection site pain
  • nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from air and moisture. It is important to maintain a room temperature between 1 degree and 30 degrees.

Appearance and packaging

Appearance

A colorless or light yellow liquid filled in a colorless transparent plastic container for injection.

Package unit

100 milliliters/vial, 200 milliliters/vial

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.